LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

Took profit yesterday, just holding free shares now. Keeping an eye on these though as there is certainly a big market for Sirco/Friutflow; whether or not it can be exploited to the full is another matter!

being hearing that for a very long time now, and it's about time the company came up with some contracts or similar

.

Still in....I just think that a rns will arrive with a big contract of a sort and the sp will take off like the space shuttle.....well I'm hoping anyway.....

Fruitflow has won two awards in Madrid this evening....one being overall winner for product innovation of the year!!
Will this effect a rise in the share price tomorrow??

Two of the judges were from Unilever and Danone and there was major interest from a Britvic buyer at the Fruitflow stand at the HIE exhibition at the same venue!!
10p by xmas......buy buy buy!!
By the way get on facebook and have a look at the Sirco Fruitflow page.

no ... awards are just food industry flannel .... "interest" has no value either .... it's orders that are needed

Many many thanks to The Don on iii

Just back from the exhibition and we are very glad we attended the Hi Excellence Awards ceremony.

In front of an audience of about 300 packed into the theatre not only did DSM win the Heart Health category award for Fruitflow they also won the overall Hi Excellence Innovation of the Year award which is awarded to the company & product the judges felt had shown a clear understanding of the health benefits and had been specific in its consumer target. Henry Dixon, Chairman of the judging committee presented the award to Steven Morrison of Provexis & Jacob Bauly, Market Development Manager of DSM.

To say we were delighted is an understatement and going by the smile on both the above guys faces it was clear that they were absolutely thrilled. We managed to get through the surrounding well wishers and the photograph of Mrs Don actually holding the award flanked by Steven Morrison & Jacob Bauly is uploading on Facebook as we speak ! We even had people shaking our hands as Mrs Don had told them we had invested in Fruitflow, brilliant !!

The whole presentation ceremony was officially filmed and I would imagine it will be available on line in the next few days, we have a small clip of the first award for Fruitflow and will try to get it online tonight, excuse the 2 ignorant talkers in front for the first minute or so, I moved to the side and managed to get a better view and better coverage.

We shook hands with Steven Morrison and gave him and the rest of the DSM team our best wishes for the future, it was impossible to ask him any questions as in all honestly it was not the time nor the place, there were people behind us waiting to take our place in the queue for a photograph with the overall winners.

We have left the exhibition with a totally different concept as to how big Fruitflow can be, it really is DSMs jewel in the crown and only by being there and talking to them directly do you start to understand the respect they have for Provexis, Steven Morrison and the vision they have for the success of Fruitflow.

I would assume the media may pick up on the tremendous success of Fruitflow in the awards and will only highlight the tremendous potential it has, you dont win the top award for nothing!

Not sure if an RNS will be issued to inform stakeholders of its success at the awards ceremony, I sincerely hope they do as it demonstrates just how high it is rated by the judging panel, which included Henry Dixon (Barret, Dixon & Bell) Georges Bruelle, (Danone) Jeff Nuss (Kelloggs) & Prof. I.R. Albert Zwijgers (Unilever) amongst them.

Top, top people !!

We look forward to a great future with Fruitflow. GLA

fuck the awards; fuck the judging panel ..... "great future" will only come from committed and signed contracts ..... so far - all guff!

All in goog time cynic. Aspirin didnt become a mass market product overnight. Fruitflow will be huge in time. aimvho

some will already have been waiting 3.5 years and made very little progress!

PXS sp performing to form! .... what a load of rubbish they are - and for my sins i hold some too

Patience cynic.....the sp is quite low considering the potential...if you want some : buy now...before it goes to 10p plus as I expect them to win big contracts and there should be big percentage royalties rolling in soon....I mean ; an aspirin replacement ?...sounds fabulous with the sp being knocked down....at 8p plus I'd be grumbling about getting in but not at this price.

i wonder if i shall live long enough to see 10p

Only 36 days to Xmas cynic. Forget the oranges and apples or whatever healthy stuff goes in your Xmas stocking. Stick Sirco in it instead! ;o)

give your mrs one tooo.....................sirco that is.,.

Or, to put it another way.....Sirco is good for your Elf!

An RNS at last:

Provexis PLC



Development Agreement with DSM Nutritional Products



Provexis plc ("Provexis" or the "Company"), the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, announces that it has entered into a development agreement (the "Agreement") with DSM Nutritional Products ("DSM" and together with Provexis, the "Partners") to commercialise DSM owned intellectual property through the development of a product for the promotion of healthy blood glucose levels.



Under the Agreement, it is the intention that Provexis will develop a cost effective product, carry out clinical trials and gain the necessary regulatory clearances. DSM will contribute intellectual property and know-how to the development programme and will assist in areas such as obtaining regulatory clearances. The Partners will together identify the most appropriate commercialisation arrangements before the product is launched.



Maintaining healthy blood glucose levels, both before and after meals, is of increasing importance as it is believed that high blood glucose levels contribute to obesity and diabetes. The benefits of maintaining healthy blood glucose levels are considered to be increasingly relevant not only in diabetics and pre-diabetics but also in the wider population as a whole. It was estimated in 2010[1] that 25.8 million US residents (8.3% of the population) suffer from diabetes, with an estimated 79 million Americans over the age of 20 having pre-diabetes. It is believed that people with diabetes have a higher than average risk of developing cardiovascular disease[2]. Sales of foods and drinks specifically marketed to address heart health conditions are growing strongly and were forecast to reach $7.7 billion in the US and Europe in 2010[3].



Stephen Moon, CEO of Provexis commented:



"We are delighted to announce this development agreement which further extends our strategic relationship with DSM Nutritional Products. In recent months we have assessed the technology and we believe that it will strengthen further our pipeline of cardiovascular-related technologies. The collaborative approach facilitated by the agreement will allow for the most effective commercialisation of the technology. In addition to this important new pipeline technology, the management team continues to assess further potential acquisitions."

this (and ANR) has been one of my prize stinkers which i try to sweep and keep under the carpet

I was once very enthusiastic about this one but am so glad I sold a long time ago, though by no means at its peak because as that time I was 'sure' it would go further... Greed, as always